Compară metode
Examinează metodele selectate una lângă alta; rândurile care diferă sunt evidențiate.
| Analiza Proteomică Bayesiană× | Analiza Bayesiană a Metabolomicii× | |
|---|---|---|
| Domeniu | Bioinformatică | Bioinformatică |
| Familie | Process / pipeline | Process / pipeline |
| Anul apariției≠ | 2000s (major developments 2003–2010) | 2005–2010 |
| Autorul original≠ | Multiple contributors; foundational statistical frameworks by Nesvizhskii, Kall, Choi, and colleagues | Simon Rogers, Mark Girolami and colleagues (Bayesian NMR metabolomics framework, ~2009); broader Bayesian metabolomics developed through 2000s–2010s |
| Tip≠ | Probabilistic inference pipeline | Probabilistic statistical pipeline |
| Sursa seminală≠ | Kall, L., Canterbury, J. D., Weston, J., Noble, W. S., & MacCoss, M. J. (2008). Semi-supervised learning for peptide identification from shotgun proteomics datasets. Nature Methods, 5(11), 923–925. link ↗ | Rogers, S., Scheltema, R. A., & Girolami, M. A. (2009). Bayesian analysis of metabolomic NMR data. Bioinformatics, 25(14), 1809-1815. link ↗ |
| Denumiri alternative | Bayesian protein quantification, Bayesian peptide inference, probabilistic proteomics, Bayesian mass spectrometry analysis | Bayesian metabolomics, probabilistic metabolomics, Bayesian metabolite profiling, Bayesian metabolic flux analysis |
| Înrudite | 6 | 6 |
| Rezumat≠ | Bayesian proteomics analysis applies probabilistic models to mass spectrometry data to identify peptides, infer protein presence, and quantify differential protein abundance across conditions. By encoding prior knowledge and propagating uncertainty through each step of the pipeline, Bayesian approaches produce calibrated posterior probabilities of identification and quantification rather than simple point estimates, enabling more principled control of false discovery rates and more honest reporting of uncertainty than purely frequentist alternatives. | Bayesian metabolomics analysis applies probabilistic inference to metabolite abundance data — typically from mass spectrometry or NMR spectroscopy — to identify differentially abundant metabolites, annotate spectral features, and integrate pathway knowledge. By encoding prior biological knowledge into prior distributions and propagating uncertainty throughout the analysis, it yields more calibrated probability statements about metabolic differences than classical frequentist testing alone. |
| ScholarGateSet de date ↗ |
|
|